Dirk Weber is an MD, PhD with 20+ years of Pharma Industry experience in Drug, Business and Corporate Development from executive leadership positions at Merck Serono, Novartis and Takeda and entrepreneurial experience from co-founding 2 Biotech companies leading them as Chief Medical Officer to clinical stage. Dirk has worked in early and late-stage Clinical Development, conducted successful filings, led submissions teams, has developed a regional oncology Medical Affairs organization (MSL, Medical Director) and has extensive experience in conducting Medical Affairs activities to prepare for successful commercial product launches. He has longstanding oncology drug development expertise in haemato-oncology and worked on major oncology brands for Novartis (Afinitor – Breast), Merck Serono (Erbitux – CRC) and with Takeda on ADC Adcetris (Hodgkin and non-Hodgkin Lymphomas), proteasome inhibitor Ixazomib (Multiple Myeloma) and on IO drug Mepact (Osteosarcoma). He has excellent regulatory filing and launch experience throughout career.